Metreleptin in Anorexia Nervosa
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Anorexia Nervosa
In brief
The treatment of anorexia nervosa often proves to be difficult. There are no drugs that work specifically for the treatment of anorexia nervosa. Experimental administration of metreleptin (synthetically produced leptin) to patients with anorexia nervosa has produced positive results. This study tests the effect of metreleptin in comparison with placebo, which could potentially make treatment easier. The aim of the study is to investigate whether treatment with metreleptin can help to reduce the symptoms of anorexia nervosa and improve mood and weight.
Key facts
- Study ID
- NCT06305182
- Run by
- Gabriella Milos
- People needed
- 50
- Starts
- 2024-05-31
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-07-29
Who can join
Age: 17 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Eating Disorder Unit, Clinic of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich — Zurich, Canton of Zurich, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.